medi8897
Showing 1 - 3 of 3
Respiratory Syncytial Virus Infections Trial in Worldwide (MEDI8897, Palivizumab)
Active, not recruiting
- Respiratory Syncytial Virus Infections
- MEDI8897
- Palivizumab
-
Anaheim, California
- +127 more
Aug 18, 2022
Respiratory Syncytial Virus Infections Trial in Worldwide (MEDI8897, Placebo)
Active, not recruiting
- Respiratory Syncytial Virus Infections
- MEDI8897
- Placebo
-
Birmingham, Alabama
- +214 more
Feb 4, 2022
Respiratory Syncytial Virus Infections Trial in Worldwide (MEDI8897, Placebo)
Completed
- Respiratory Syncytial Virus Infections
- MEDI8897
- Placebo
-
Birmingham, Alabama
- +160 more
Sep 24, 2019